Document is current
Any future updates will be listed below
-
Authors
Peterson, Quinn P.
Veres, Adrian https://orcid.org/0000-0002-3849-3475
Chen, Lihua
Slama, Michael Q. https://orcid.org/0000-0002-0808-3547
Kenty, Jennifer H. R. https://orcid.org/0000-0003-0974-9643
Hassoun, Shaimaa
Brown, Matthew R.
Dou, Haiqiang
Duffy, Caden D.
Zhou, Quan
Matveyenko, Aleksey V.
Tyrberg, Björn https://orcid.org/0000-0003-0976-1220
Sörhede-Winzell, Maria
Rorsman, Patrik
Melton, Douglas A. https://orcid.org/0000-0002-1623-5504
-
Funding
Funding for this research was provided by:
Leona M. and Harry B. Helmsley Charitable Trust
JDRF
- License Information
-
More Information
Article History
Received: 21 November 2018
Accepted: 10 April 2020
First Online: 7 May 2020
Competing Interests
: Q.P.P., A.V., and D.A.M are all inventors on patent applications for content described in this manuscript. D.M. is a founder of Semma Therapeutics and equity holder of Semma/Vertex. Semma/Vertex has licensed technology developed in D.M.’s lab. L.C., B.T., and M.S.W. are employees at AstraZeneca. The remaining authors declare no competing interests.
